{
    "2021-05-20": [
        [
            {
                "time": "2022-10-15",
                "original_text": "Eli Lilly's Tirzepatide Non-Inferior To Titrated Insulin Glargine In Type 2 Diabetes Patients",
                "features": {
                    "keywords": [
                        "Tirzepatide",
                        "Non-Inferior",
                        "Insulin Glargine",
                        "Type 2 Diabetes"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-10-15",
                "original_text": "Lilly's tirzepatide achieves all primary and key secondary study outcomes against insulin glargine in adults with type 2 diabetes and increased cardiovascular risk in SURPASS-4 trial",
                "features": {
                    "keywords": [
                        "tirzepatide",
                        "achieves",
                        "primary",
                        "secondary",
                        "outcomes",
                        "insulin glargine",
                        "type 2 diabetes",
                        "cardiovascular risk",
                        "SURPASS-4"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}